Current Corporate Partners
AbbVie
About Us:
AbbVie is a leading global biopharmaceutical company dedicated to discovering, developing, and delivering innovative solutions in healthcare. Our mission is to improve the lives of people around the world by addressing some of the most complex and critical health challenges of our time.
​
With a strong commitment to research and development, we strive to advance the frontiers of science and medicine, focusing on areas such as immunology, oncology, neuroscience, virology, and more. By leveraging our expertise, state-of-the-art facilities, and collaborations with healthcare professionals, patients, and partners, we aim to develop transformative therapies that make a meaningful difference in patients' lives.
Aurinia Pharmaceuticals
About Us:
​Aurinia is a biopharmaceutical company focused on developing therapies for patient populations impacted by serious diseases with a high unmet medical need. Aurinia received FDA approval for their first commercially available drug product in January 2021. Please visit www.AuriniaLN.com to learn more.
Johnson & Johnson
About Us:
At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Learn more at https://www.jnj.com/ or at www.janssen.com/johnson-johnson-innovative-medicine. Follow us at @JanssenUS and @JNJInnovMed
Pfizer
About Us:
Pfizer’s purpose—Breakthroughs that change patients' lives—fuels everything we do and reflects our passion for building on our legacy as one of the greatest contributors of good to the world. We innovate every day to make the world a healthier place. Our purpose ensures that patients remain at the center of all we do. We live our purpose by sourcing the best science in the world; partnering with others in the healthcare system to improve access to our medicines; using digital technologies to enhance our drug discovery and development, as well as patient outcomes; and leading the conversation to advocate for pro-innovation/pro-patient policies. Every decision we make and every action we take is done with the patient in mind—and to nurture an environment where breakthroughs can thrive.
Sanofi
About Us:
We are an innovative global healthcare company, driven by one purpose: we chase the miracles of science to improve people’s lives. We are dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the center of our ambitions.
UCB
About Us:
A global biopharma company, inspired by the needs of people living with severe diseases. At UCB, we are consistently delivering on our commitment to improve the lives of people living with severe neurological and immunological conditions. And thanks to our focused, innovative and trusted solutions, our business is strong, with total revenue reaching €5.8 billion in 2021.
This success is powered by the approximately 8,600 people – from our headquarters in Belgium and across nearly 40 countries worldwide. Our people have lived our purpose each day since 1928, making critical investments in biopharmaceutical research and leading innovations that strive to achieve a meaningful impact on the lives of those we serve.